Skip to content

Clinical Study on the Syndrome of Kidney Deficiency in Knee Osteoarthritis and the Intervention with Traditional Chinese Medicines for Kidney Tonification

Clinical Study on the Syndrome of Kidney Deficiency in Knee Osteoarthritis and the Intervention with Traditional Chinese Medicines for Kidney Tonification

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001329
Enrollment
Unknown
Registered
2026-05-26
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthritis

Interventions

The herbal intervention group for the kidney deficiency syndrome in KOA:There were 49 patients each with kidney yin deficiency, kidney yang deficiency, and kidney yin-yang deficiency. On the basis of
KOA Kidney Deficiency Syndrome Conventional Treatment Group:On the basis of oral administration of hydrochloric acid chondroitin, a placebo was given.

Sponsors

No. 613, Huangpu Avenue West, Tianhe District, Guangzhou City, Guangdong Province. The First Affiliated Hospital of Jinan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Age: 60 - 75 years old, gender not restricted. 2) Diagnosed with OA based on X-ray/MRI/clinical symptoms. 3) Kellgren & Lawrence grade between 0 and II. 4) Meets the diagnostic criteria of kidney deficiency syndrome (kidney yin deficiency, kidney yang deficiency, or both kidney yin and yang deficiency) in traditional Chinese medicine. 5) Agrees to participate in this study and signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Secondary arthritis: Rheumatoid arthritis, ankylosing spondylitis, gouty arthritis, infectious arthritis, traumatic arthritis, etc. 2) Severe joint structural abnormalities: Deformed, disabled, or dysfunctional knee joints. 3) Complicated with systemic diseases: Severe heart, liver, or kidney failure, malignant tumors, blood system diseases, immune deficiencies, tuberculosis, hemophilia, mental disorders, etc. 4) Received joint cavity injections (such as hormones, hyaluronic acid) within the past month, or have been taking long-term hormones or immunosuppressants. 5) Women who may be pregnant or planning to get pregnant.

Design outcomes

Primary

MeasureTime frame
Kidney Deficiency Score and Therapeutic Effect Evaluation Scale;WOMAC Score Scale;HSS Rating Scale;Degree of swelling in the knee joint;VAS pain score;

Secondary

MeasureTime frame
Measurement of X-ray joint space width and bone spurs;MRI MOAKS Rating Scale;

Countries

China

Contacts

Public ContactHuantian Zhang

The First Affiliated Hospital of Jinan University

zhanghuantian@jnu.edu.cn18820797138

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026